Reproductive Endocrinology & Women's Health

The intersection of reproductive endocrinology & women's health with diabetes presents unique challenges across different life stages. Polycystic ovary syndrome (PCOS) and gestational diabetes mellitus (GDM) are common metabolic disorders linked to insulin resistance, affecting fertility and pregnancy outcomes. Hormonal fluctuations influence glycemic control, making diabetes management more complex during puberty, pregnancy, and menopause. Emerging research highlights the impact of sex hormones on glucose metabolism and the role of individualized treatment approaches in optimizing reproductive health. Advancements in assisted reproductive technologies, targeted hormonal therapies, and lifestyle interventions improve fertility outcomes and maternal health. A comprehensive approach integrating endocrinology, obstetrics, and metabolic management is essential for addressing these challenges effectively.

Committee Members
Speaker at Diabetes 2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes 2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes 2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes 2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes 2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes 2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes 2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes 2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes 2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes 2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp